Physician profile
Mark Sison
NPI 1275777583
$14,745.57
in general payments reported to CMS, 2019-2025
25 companies · $3,978 in 2025
The $3,978 reported for 2025 was more than what 96% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $358 · 2021: $412 · 2022: $3,259 · 2023: $2,241 · 2024: $3,539 · 2025: $3,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,229 · Travel and Lodging: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,228.50 |
| Travel and Lodging | $1,528.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $3,166.01 | 2021-2024 | Painteq |
| Boston Scientific Corporation | $2,702.48 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,460.40 | 2019-2024 | Senza |
| Abbott Laboratories | $1,387.37 | 2023-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,149.95 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Vertos Medical, INC. | $1,079.80 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $832.15 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $771.57 | 2024-2025 | Sprint Pns System |
| Medtronic USA, INC. | $761.85 | 2019-2020 | |
| Globus Medical, INC. | $314.84 | 2025 | Senza |
| Biotronik Nro, INC. | $214.07 | 2023-2025 | Prospera, Biotronik |
| Nalu Medical, INC. | $187.72 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $144.07 | 2025 | |
| Avanos Medical | $142.96 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.72 | 2025 | Jardiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $67.61 | 2024 | Tenjet |
| Radius Health, INC. | $56.57 | 2025 | |
| Amgen INC. | $50.17 | 2019-2024 | Evenity, Prolia |
| Relievant Medsystems, INC. | $44.64 | 2023 | Intracept |
| Curonix LLC | $24.77 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $22.94 | 2025 | Pangea |
| Orthofix Medical, INC. | $17.61 | 2023 | Spinal-Stim, Spinal-Stim |
| Stimwave Technologies Incorporated | $16.67 | 2019 | |
| Vertiflex, INC. | $14.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$150,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.